Fig. 1From: A three-gene expression-based risk score can refine the European LeukemiaNet AML classificationGenome-wide approach to identify a robust prognostic clinical score in AML patients. The schematic overview how to identify a robust AML scoring model using four different expression data sets from TCGA, NTUH, and two independent data sets of the AMLCG-1999 trial (GSE12417-GPL96 and GSE12417-GPL570) is shown. Statistical analysis was conducted either by uni- or multivariate Cox regression analysisBack to article page